Objective: rs12576775 was found to be associated with bipolar disorder (BD) in a genome-wide association study (GWAS). The GWAS signal implicates genes for the microRNAs miR-708 and miR-5579 and the first exon of the Odd Oz/ten-m homolog 4 gene (ODZ4). In the present study, miR-708, its surrounding region, and its targets were analyzed for potential BD-associated functional variants.
1
Bipolar disorder (BD) is a common disease with a worldwide average population prevalence of 1.4%, which rises to 2.4% if bipolar spectrum disorders are included.
1 BD is strongly familial, with a 10-fold increase in risk to the relatives of BD probands. 2 Estimates of the heritability of BD range from 79% to 93%. [3] [4] [5] [6] Genome-wide association studies (GWAS) have identified a number of common polymorphisms which are convincingly associated with BD. 7, 8 The Psychiatric This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
(P=4. 4 × 10 −8 ). 9 Both Green et al. 10 and Mühleisen et al. , respectively). A large intergenic region distal to rs12576775 and a proximal genomic region with a high recombination rate in intron 1 of ODZ4 effectively restrict the BD association region to the genomic interval that includes the first exon of ODZ4 and the microRNA (miRNA) genes miR-708 and miR-5579. 9 Of the two miRNA genes, only miR-708 has been experimentally validated and it is known to be expressed in the human nervous system.
12
The role of miRNAs in psychiatric disorders has recently become prominent as a result of findings in schizophrenia (SCZ). The PGC-SCZ working group reported GWS with a SNP association in the third intron of the primary transcript of miR-137. 13 There is evidence that genetic ; and rs11122396 in the 3ʹ UTR of the disrupted-in-schizophrenia-1 (DISC1) gene disrupted miR-135b-5p-mediated control of DISC1 expression.
21
The evidence that implicates miRNAs in the etiology of BD is not as strong as it is for SCZ. However, recent data have provided increasing support for the hypothesis that miRNAs also play a role in the etiology of BD.
In the largest GWAS of BD to date, a SNP in an intergenic region flanking miR-2113 on chromosome 6q16.1 was the eighth strongest finding. 11 A gene-based analysis of all known autosomal microRNAs using the same GWAS data found a significant association between nine microRNAs (including miR-708) and BD. In the present study, miR-708, its surrounding region, and its targets were analyzed for possible functional variants associated with BD.
| MATERIALS AND METHODS

| Subjects
The study included 2078 research subjects with bipolar I ( Affective Disorder Schedule. 18 Participants fulfilling the research diagnostic criteria 31 for BD were included. An analogous protocol was used to recruit participants with SCZ. Blood or saliva samples were collected for all participants. DNA from blood samples was extracted using a standard phenol-chloroform method and from saliva samples using the Oragene protocol for DNA extraction (DNA Genotek, Ottowa, ON, Canada).
| Detection and evaluation of new variants
High-resolution melting (HRM) variant screening was used to iden- Hill, UK). Primer sequences and reagents are shown in Table S1 .
Samples with abnormal HRM curves were then sequenced using the BigDye terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Warrington, UK) on an ABI 3730xl DNA Analyzer (Applied Biosystems).
Sequencing data were analyzed using the Staden Package (http://staden.sourceforge.net/). 32 The reference minor allele frequency (MAF)
for the general population was evaluated in the data from the 1000 Only variants with a MAF lower than 0.01 in the general population were considered for further analysis.
| Genotyping
Genotyping of the selected SNPs was performed in an enlarged sample of 2078 cases with BD and 1355 ancestrally matched controls. It was performed in-house using the allele-specific polymerase chain reaction (PCR), using KASPar reagents (LGC Genomics, Hoddesdon, UK) on a LightCycler 480 real-time PCR machine. Allele-specific primers were designed for each of the SNPs using Primer Picker (KBiosciences,
LGC Genomics, Hoddesdon, UK; primer sequences are listed in Table   S2 ). The variants were also genotyped in 1305 SCZ samples. For all SNPs, 97% of samples were successfully genotyped. Genotyping for each heterozygote sample was repeated at least twice. All of these data were analyzed to confirm Hardy-Weinberg equilibrium. Allelic associations for SNPs were performed using Fisher's exact test.
Significance values shown for all analyses are uncorrected for multiple testing, and a cut-off significance value of P<.05 was used.
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| Detection and evaluation of variants in the hasmiR-708 binding sites
| Imputation and analysis of BD GWAS data
UCL BD and control GWAS data were included in the PGC-BD dataset. 37 These data have been subjected to a standardized quality control and imputation pipeline (https://sites.google.com/a/broadinstitute. org/ricopili/). Association testing was performed using PLINK2. 38 
| RESULTS
| Variant selection and genotyping
Three single nucleotide variants were detected by HRM analysis across the region selected to be analyzed: rs56158925, rs754333774, and rs768049399 (Table 1) Wellderly subjects or in the UK10K cohorts. rs754333774 was also not reported in the 1000G project or in the UK10K cohorts however it was detected in one of 534 individuals from the Wellderly sample (Table 1 ).
The estimated MAF of this variant in these two datasets is 0.0017. The genomic reference sequence used was GRCh37/hg19. The variant position in the sequence is indicated with boldened letters. 1000G, 1000 Genome Project; APOC3, apolipoprotein C-III; Eur, European population; Exac, Exome Aggregation Consortium; GALNT13, polypeptide N-acetylgalactosaminyltransferase 13; nd, not detected; SNP, single-nucleotide polymorphism; UTR, untranslated region; SLC22A23, solute carrier family 22 member 23; ST6GALNAC4, ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4.
was detected in three cases with BD, two cases with SCZ, and no controls (Table 2) .
Bioinformatic transcription factor binding analysis of the effect of rs754333774 did not identify consistent predictions for altered binding. By contrast, the variant allele of rs768049399 was predicted to destroy a binding site for the CCAAT/enhancer-binding protein beta transcription factor and to create a binding site for five transcriptional factors: hepatocyte nuclear factor (HNF)-3α; TATA box-binding protein; homeobox protein D8; HNF-1C; and HNF1-B. the European-only sample from the 1000G project (Table 3) . Data were available only for rs5128 in the ExAC database, and these were similar to those of the BD WGS sample. The 3ʹ UTRs of the remaining genes were not included in the exome sequencing data in the ExAC database. Association testing of GWAS data for the first 491 UCL BD cases and 495 UCL controls, imputed using the 1000G project data as a reference panel, did not show evidence for involvement of rs5128 or rs707082 with BD (P=.5214 and .4286, respectively); rs1043026 and rs5873874 were not reliably imputed (Table S3) .
| Variants in miR-708 binding sites
| DISCUSSION
The potential role of miRNAs in psychiatric disorders has recently been highlighted by GWS association findings with SNPs within miR-137 and SCZ. 13 Several reports have implicated microRNAs in BD, both genetically and biologically. 11, 23, 25, 26, 39, 40 The PGC-BD group performed a combined analysis of GWAS data that identified a GWS intronic variant in ODZ4 (TENM4), rs12576775. 9 This association has been confirmed by two other independent studies.
10,11
The two variants in miR-708 with a MAF lower than 0.01 (rs768049399 and rs754333774) were genotyped in our BD and control cohorts. The strong prior findings with miRNA genes in SCZ led us to genotype the selected variants in our SCZ cohort, in addition to the subjects with BD and control subjects.
The rare allele of rs754333774 was found only in individuals with BD or SCZ; in our own data and, this finding was not statistically significant. This variant was detected in a single individual from the Wellderly sample but was absent in a substantially larger number of individuals from the UK10K cohorts. Together the frequency of this variant in the combined UK10K cohorts and Wellderly sample was lower than that in our BD and SCZ case cohorts. This finding is intriguing but requires validation in large independent samples of subjects with BD and or SCZ and healthy controls. No support for a role for rs768049399 in BD (and/or SCZ) was found.
In order for microRNAs to regulate gene expression, they need to bind to a target region, normally in the 3ʹ UTR of a gene. It is important that nucleotides 2-8 of the miRNA have a perfect match with their target, and this region is defined as a seed region. The miRNA binding site and, more specifically, the seed regions are well conserved;
they are more likely to reside within those targets in the transcriptome with lower variant densities, especially target regions in which nucleotides have low mutation frequencies. 41 Analysis of enrichment of GWS signals for miRNA genes and their putative target regions implicated miR-137 and its pathway in SCZ in different populations. 42, 43 With the advent of WGS, it is therefore possible to implicate not only regions, but also specific variants, in disease. WGS data for 99 BD exome sequencing. However, as larger scale WGS datasets become available, variation in 3'UTRs and intronic/intragenic regions will be better described, making it possible to begin to understand the functional role of these regions.
| CONCLUSIONS
In summary, we report a single recurrent variant located close to in the miR-708 gene that may have a role in susceptibility to BD and/ or SCZ. This finding awaits replication in independent SCZ and BD cohorts, as does a functional analysis of the potential consequences of this variant.
